From January 23-27, 2001, co-therapists Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., will conduct a therapist training program for the new Israeli clinical team. The meeting will appropriately …
From January 23-27, 2011, MAPS Clinical Investigators Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., conducted a training course for therapists who will be conducting the treatment sessions in MAPS’ …
On January 10, 2011, our clinical team submitted the documents detailing our new protocol for our new Israeli study of MDMA-assisted psychotherapy for PTSD to the Institutional Review Board (IRB) at Beer …
On January 10, 2011, the final long-term follow-up visit was completed in MAPS’ Swiss study of MDMA-assisted psychotherapy for PTSD. The final subject (out of 12 total) was interviewed 12 months …
Our Swiss MDMA/PTSD study collected video from nearly all of the sessions with treatment subjects. We are now preparing a method to archive the videos for future research purposes. This collection of video …
On Nov. 1, 2010, Pharmacist Colin Holyk from Kerrisdale Pharmacy resubmitted his application for a “licensed dealer permit” to Health Canada in order to import MDMA for our Canadian MDMA/PTSD …
On October 20, Rick visited with Clinical Investigator Nasser Shuriquie, M.D., at Al-Rashid Hospital to discuss our Jordanian MDMA/PTSD study. The protocol was approved by the Al Rashid Institutional Review …
From Oct. 18- 23, MAPS Executive Director Rick Doblin, Ph.D. will be in Israel and Jordan, where he will meet with Clinical Investigator Moshe Kotler, M.D., of our Israeli study, to discuss starting a …
On Oct. 2, Jordanian Principle Investigator Nasser Shuriquie, M.D., attended a workshop with the Jordanian Food and Drug Administration (JFDA) to enhance his knowledge about clinical research procedures …
The experimental treatments in our Swiss MDMA/PTSD study were completed in January 2010. In January 2011, we will collect follow-up data from one remaining subject. The clinical research team is developing …
On Oct 14, 2010, Rick Doblin, Ph.D., met in Tel Aviv, Israel, with Moshe Kotler, M.D., Principle Investigator of MAPS’ Israeli MDMA/PTSD study. They discussed the abbreviated clinical report of the …
After more than a month of waiting, Health Canada has requested additional information from the Canadian pharmacist we are working with to obtain import permits and licensing for encapsulating the MDMA …